Cellebrite DI (CLBT) News
What's actually happening: chronological and provenance-stamped. News is context, not a signal.

Cellebrite DI combines double-digit growth and an attractive valuation, positioning the stock for a potential reversal of its multiyear downtrend. Q3 revenue rose 18% to $149 million and ARR increased 20% to $528.5 milli…

Cellebrite DI reported third-quarter results above key estimates on November 12, 2026, yet its shares traded down about 14% after the same report trimmed full-year revenue guidance again. Investors who lost money in the …

Cellebrite DI Ltd. ( CLBT ) Q3 2026 Earnings Call November 12, 2026 8:30 AM EST Company Participants Andrew Kramer - VP of Investor Relations & Treasury Shiven Ramji - CEO & Director David Barter - Chief Financial Office…

Cellebrite DI NASDAQ: CLBT reported third-quarter revenue and annual recurring revenue growth of 18% and 20%, respectively, as international sales and improving U.S. federal demand helped the digital forensics company ex…

Cellebrite DI Ltd. (CLBT) came out with quarterly earnings of $0.17 per share, in line with the Zacks Consensus Estimate.…

Third-Quarter ARR Growth of 20% and TTM Free Cash Flow Margin of 31% Net income of $26.7 million; Non-GAAP net income of $45.6 million and adjusted EBITDA of $53.6 million, 36% adjusted EBITDA margin TYSONS CORNER, Va. a…

TYSONS CORNER, VA and PETAH TIKVA, ISRAEL, Nov. 9, 2026 /PRNewswire/ -- Cellebrite DI Ltd. (NASDAQ: CLBT), a global leader in AI-powered Digital Investigative and Intelligence solutions for the public and private sectors…

Former Okta and SAP strategy leader brings AI, platform and M&A expertise to accelerate Cellebrite's growth TYSONS CORNER, Va. and PETAH TIKVA, Israel, Nov. 5, 2026 /PRNewswire/ -- Cellebrite (Nasdaq: CLBT), a global lea…

NEW YORK, Oct. 22, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NASDAQ: CLBT).…

Investigators report dramatic gains in what they uncover using Agentic AI vs. manual review; the Autumn 2026 Release brings expanded device and operating system access TYSONS CORNER, Va.…

/PRNewswire/ -- Cellebrite DI Ltd. (NASDAQ: CLBT), leader mondial des solutions numériques d'investigation et de renseignement basées sur l'IA pour les…

TYSONS CORNER, VA and PETAH TIKVA, ISRAEL, Oct. 20, 2026 /PRNewswire/ -- Cellebrite DI Ltd. (NASDAQ: CLBT), a global leader in AI-powered Digital Investigative and Intelligence solutions for the public and private sector…

Cellebrite DI Ltd. (NASDAQ: CLBT - Get Free Report) CFO David Barter sold 12,134 shares of Cellebrite DI stock in a transaction that occurred on Friday, October 16th. The shares were sold at an average price of $11.21, f…

NEW YORK, Oct. 15, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NASDAQ: CLBT).…

New York, New York--(Newsfile Corp. - October 8, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NASDAQ: CLBT).…

NEW YORK, Oct. 8, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NASDAQ: CLBT).…

New York, New York--(Newsfile Corp. - October 6, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NASDAQ: CLBT).…

Boston, Massachusetts--(Newsfile Corp. - October 2, 2026) - Block & Leviton is investigating Cellebrite DI (NASDAQ: CLBT) for potential securities law violations. Investors who have lost money in their Cellebrite DI inve…

New York, New York--(Newsfile Corp. - October 2, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NASDAQ: CLBT).…

NEW YORK, Oct. 1, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NASDAQ: CLBT).…

New York, New York--(Newsfile Corp. - September 30, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NASDAQ: CLBT).…
Kept in their own lane. A press release is the company talking, not reporting.
No upcoming events in the feeds.
Quiet tape today.

